2004: Foundation of STX-Med with the mission to research and develop practical innovations in the field of electronics and bio-electronics for use on humans.

The STX-Med project was formed from the collaboration of two founders who are experts in bio-engineering; one is an engineer and the son of a physician, while the other is a physician and the son of an engineer.

Pierre-Yves MULLER :

Doctor of physics, having graduated from the University Geneva (Switzerland).
This expert in electronics and micro-electronics was made aware of the medical applications of the discipline by his father, Professor Muller of the department of internal medicine at the University Hospital of Geneva. Since qualifying as physics engineer, he has always worked in research and the development of innovative electronic devices. He is also the founding engineer for all the technology used in Compex equipment.

Pierre François RIGAUX :

Doctor of medicine, graduated from the University of Liège (Belgium).
He also graduated in electronics from the Technical University of Saint Laurent. After several years of practising medicine both in a hospital and private setting, he became a scientific consultant for several European companies who made medical equipment. Already made aware of the technology by his father, an engineer, he stepped up his role as scientific adviser and became Medical Director at Compex in Switzerland, and then Vice President of Rehabilicare in the USA.

The two founders have worked together for 20 years to develop several unique and innovative medical devices in the fields of ultrasound, neuro-stimulation, electromyography and various forms of bio-signal analysis. The pair have extensive expertise in recording the electrical signals emitted by the human body that act electrically on the nerves and muscles.

2005: Launch of CEFALY project®

Cefaly® project: external cranial neurostimulation. Cânaial neurostimulation was existing only with invasive devices. STX-Med decided to start lancer a series of technical and clinical to develop a new technology: making feasible non-invasive cranila neurostimulation.

2007: Workflows control & certifications

• Implementation of an integrated control structure in all workflows from purchases to the end customer.
• Certification to ISO 9001:2000 and ISO 13485: 2003.

2008: Launch of Cefaly® & new research programs

• Launch of Cefaly®.
  Cefaly® is the first external neurostimulation device for the treatment and the prevention of migraines and headaches. This unique medical device has enjoyed tremendous success since it was launched. The improvement in the patients' quality of life generates a significant word-of-mouth recommendation.
• Presentation of Cefaly® at the Medica trade fair in Düsseldorf.
  The company's stand was under siege from distributors from all over the world eager to learn about and try the Cefaly®.
• Launch of new research projects in the field of neurostimulation in order to deliver long-term new method to treat chronic pain and new medical applications for Cefaly® Technology.

2009: Presentation of Cefaly® at the Arab Health trade fair in Dubai.

As already experienced at the Medica trade fair, Cefaly® enjoyed tremendous success and firm distribution contacts were established with several countries in Middle East.

2009: Collaboration with 5 University for the evaluation of Cefaly® safety and efficacy for migraine prevention.

Two phase II clinical trials are implemented to demonstrate Cefaly® safety and efficacy in 2 indications: sedative effect and migraine prevention.

2010: Certification ISO13485 CMD CAS (for Canada)

Launch of Cefaly® in Canada and implementation of the renting test system in several European countries.

2011: BMC Neurology peer review publishes about the VIGILANCE clinical trial which demonstrates the sedative effect of Cefaly® on the central nervous system

2012: Start of TRADONI research project about chronic pain treatment.

STX-Med establishes a partnership with Liege University and the research department of the Walloon region for the launch of a research project having the objective the development of an "electronic aspirin".

2012: STX-Med winner of Grand Prix Wallonie Export

STX-Med wins the Grand Prix Wallonia Export in the young company category because of its rapid export sales since 2010.

2012: Launch of Cefaly® on the French market with a press conference in Paris

2013: Start of clinical trial for the treatment of primary chronic insomnia in France.

Start of collaboration with Prof Léger of Paris and Prof Paquereau in Poitiers for the implementation of a control clinical trial about a non-drug treatment of primary chronic insomnia.

2013: Publication in the peer review « NEUROLOGY » of the PREMICE clinical study about migraine prevention with Cefaly®.